Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Weisshaar, Stefan
NCT05457400: ENSO 16 - Study in Healthy Subjects	Completed	1	15	Europe	ENSO 16, Glucose Powder	Alpha Republic GmbH, Vienna General Hospital	Sugar; Blood, Low	06/22	07/22
NCT05217654: Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction	Recruiting	1	32	Europe	Dapagliflozin 10mg, Forxiga 10mg Tabletten, Placebo, Placebo tablets	Medical University of Vienna	Reperfusion Injury, Vascular Complications	02/23	08/23
NCT04584372: Dietary Nitrate, Vascular Function and Inflammation	Completed	N/A	20	Europe	High-nitrate intervention, HI-NI, Low-nitrate intervention, LO-NI	University of Vienna, Medical University of Vienna, Queensland University of Technology, Flinders University, Edith Cowan University	Hypertension, Inflammation	03/23	03/23